Non-small cell lung cancer (NSCLC) Tissue Microarray with 24 cases of adenocarcinoma and squamous cell carcinoma, single core per case. Pathology grade, TNM Classification and Clinical stage information available.
Price
$165.00
Catalogue No | LC489 |
Species | Human |
Fixative | Formalin |
Total Cases | 48 |
Total Cores | 48 |
Core Diameter | 1.5 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LU | LU | LU | LU | LU | LU | LU | LU |
B | LU | LU | LU | LU | LU | LU | LU | LU |
C | LU | LU | LU | LU | LU | LU | LU | LU |
D | LU | LU | LU | LU | LU | LU | LU | LU |
E | LU | LU | LU | LU | LU | LU | LU | LU |
F | LU | LU | LU | LU | LU | LU | LU | LU |
N | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|---|---|---|---|---|---|---|---|---|
1 | A1 | 49 | M | Lung | Papillary adenocarcinoma | 2 | T2N0M0 | IA | Malignant |
2 | A2 | 52 | F | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
3 | A3 | 64 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
4 | A4 | 48 | M | Lung | Adenocarcinoma (sparse) | 2 | T1AN0M0 | IA | Malignant |
5 | A5 | 65 | M | Lung | Adenocarcinoma | 2 | T2AN0M0 | IB | Malignant |
6 | A6 | 61 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
7 | A7 | 68 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
8 | A8 | 59 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
9 | B1 | 58 | F | Lung | Adenocarcinoma | 2 | T2AN0M0 | IB | Malignant |
10 | B2 | 59 | M | Lung | Adenocarcinoma | 2 | T2AN0M0 | IB | Malignant |
11 | B3 | 58 | F | Lung | Adenocarcinoma | 2 | T1N1M0 | IIA | Malignant |
12 | B4 | 63 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIA | Malignant |
13 | B5 | 70 | M | Lung | Adenocarcinoma | 2--3 | T3N1M0 | IIIA | Malignant |
14 | B6 | 53 | M | Lung | Adenocarcinoma | 3 | T1N0M0 | IA | Malignant |
15 | B7 | 40 | M | Lung | Adenocarcinoma | - | T2N0M0 | IA | Malignant |
16 | B8 | 48 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IA | Malignant |
17 | C1 | 55 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIA | Malignant |
18 | C2 | 58 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
19 | C3 | 68 | M | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
20 | C4 | 53 | M | Lung | Adenocarcinoma | 3 | T2AN0M0 | IB | Malignant |
21 | C5 | 79 | F | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
22 | C6 | 69 | M | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
23 | C7 | 56 | M | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
24 | C8 | 40 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IA | Malignant |
25 | D1 | 58 | M | Lung | Squamous cell carcinoma | 1 | T1BN0M0 | IA | Malignant |
26 | D2 | 53 | M | Lung | Squamous cell carcinoma | 1--2 | T2N1M0 | IIA | Malignant |
27 | D3 | 60 | M | Lung | Squamous cell carcinoma | 2 | T3N1M0 | IIIA | Malignant |
28 | D4 | 57 | F | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
29 | D5 | 64 | M | Lung | Squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant |
30 | D6 | 68 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
31 | D7 | 75 | M | Lung | Squamous cell carcinoma with necrosis | 2 | T3N0M0 | IIB | Malignant |
32 | D8 | 60 | F | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
33 | E1 | 57 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIA | Malignant |
34 | E2 | 57 | M | Lung | Squamous cell carcinoma | 2 | T2AN0M0 | IB | Malignant |
35 | E3 | 71 | M | Lung | Squamous cell carcinoma | 2--3 | T2N1M0 | IIA | Malignant |
36 | E4 | 63 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
37 | E5 | 52 | M | Lung | Squamous cell carcinoma | 2--3 | T2N0M0 | IB | Malignant |
38 | E6 | 60 | F | Lung | Squamous cell carcinoma | - | T2N0M0 | IB | Malignant |
39 | E7 | 48 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
40 | E8 | 56 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
41 | F1 | 61 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
42 | F2 | 54 | M | Lung | Squamous cell carcinoma | 3 | T1N1M0 | IIA | Malignant |
43 | F3 | 57 | M | Lung | Squamous cell carcinoma | 3 | T2BN0M0 | IIA | Malignant |
44 | F4 | 65 | F | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
45 | F5 | 57 | M | Lung | Squamous cell carcinoma | 3 | T3N0M0 | IIB | Malignant |
46 | F6 | 58 | M | Lung | Squamous cell carcinoma | 3 | T2N1M0 | IIA | Malignant |
47 | F7 | 50 | F | Lung | Squamous cell carcinoma | 3 | T3N3M0 | IIIB | Malignant |
48 | F8 | 51 | F | Lung | Squamous cell carcinoma with necrosis | 3 | T2BN1M0 | IIB | Malignant |
N/A | N/A | N/A | N/A | N/A | _pheochromocytoma_ Tissue Marker | N/A | N/A | N/A | N/A |